Some compounding of semaglutide and tirzepatide may still be possible under narrow legal conditions, but that is not the same as FDA authorization for mass-marketed copies. Compounded drugs are not FDA-approved, and shortage-related enforcement discretion is not a blanket, continuing permission. The FDA’s April 2026 proposal to exclude three GLP-1 ingredients from a list used by certain outsourcing facilities was a proposal—not, by itself, a final decision. Separately, an appeals court upheld FDA’s tirzepatide shortage determination; it did not approve compounded drugs.
What “keep making” means in this dispute
“Off-brand weight-loss drugs” is an informal label for compounded drugs that may contain ingredients such as semaglutide or tirzepatide. Compounding involves combining, mixing, or altering ingredients to make a drug for a particular patient or situation. It is not the same as manufacturing an FDA-approved generic.
The distinction matters for both safety and cost decisions. FDA-approved drugs undergo agency review for safety, effectiveness, and quality before marketing. Compounded drugs do not undergo that same premarket review. Their legal availability depends on the applicable compounding conditions; it does not follow simply from a patient wanting a cheaper option or a company choosing to make a copy.
| Pathway | What it means | What it does not mean |
|---|---|---|
| FDA-approved drug | The product has undergone FDA’s premarket review for safety, effectiveness, and quality. | Approval does not guarantee that a particular patient can afford or obtain it. |
| 503A pharmacy or physician compounding | Compounding is subject to the conditions applicable to this pathway, which differ from those for outsourcing facilities. | It is not general permission to manufacture copies for routine commercial sale. |
| 503B outsourcing-facility compounding | Outsourcing facilities operate under a separate set of statutory conditions, including rules relevant to bulk drug substances and copies of approved drugs. | Registration as an outsourcing facility does not itself make a compounded drug FDA-approved or exempt it from the applicable limits. |
FDA’s shortage-related enforcement discretion was time-limited and applied to certain compounders after shortage determinations. Enforcement discretion describes FDA’s approach to enforcement during a specified period; it is not an FDA approval or a permanent exemption from compounding law.
#1 Best Overall
- 12 MONTH WEIGHT LOSS TRACKER Track your weight loss journey over 12 months with a guided journal designed for recording pounds lost, body measurements, goals and progress.
- POUNDS LOST & BODY MEASUREMENTS Includes 10, 20, 30, 50 and 100 pounds lost trackers, plus body measurement tracking to help you visually follow your progress over time.
- MONTHLY STEP & FITNESS TRACKERS Plan and record movement with monthly step trackers and monthly fitness planner pages, ideal for building consistency around activity and fitness goals.
- VITAMINS, SUPPLEMENTS & REFLECTIONS Includes vitamins and supplements trackers, plus goals and reflections sections to help you stay organised and review your progress throughout the year.
- CHALLENGES TO KEEP YOU MOTIVATED Features 30 day, 12 week and 52 week challenges, giving you different ways to stay focused and create momentum across your weight loss journey.
What changed in FDA’s timeline
- October 2, 2024: FDA determined the tirzepatide injection shortage was resolved. After litigation and reevaluation, FDA issued a new resolution determination on December 19, 2024.
- February 21, 2025: FDA determined the semaglutide injection shortage was resolved. FDA said it had confirmed with the manufacturer that supply could meet present and projected national demand, while acknowledging that intermittent local supply-chain disruptions might occur.
- February 6, 2026: FDA said it intended to take steps to restrict active pharmaceutical ingredients intended for mass-marketed, non-FDA-approved compounded GLP-1 drugs. It warned companies not to describe compounded products as generic versions, the same as approved drugs, or clinically proven to produce results for patients.
- April 30, 2026: FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. The agency said it had found no clinical need for outsourcing facilities to compound those drugs from bulk substances and invited comments through June 29, 2026, before making a final determination.
- August 27, 2026: The Fifth Circuit affirmed the district court judgment in Outsourcing Facilities v. FDA, a challenge concerning FDA’s tirzepatide shortage determination.
The April proposal and the August court ruling are different actions. The proposal described a possible future change to the 503B bulks list; the court considered whether FDA had adequately explained its tirzepatide shortage determination. Neither should be described as FDA approval of compounded GLP-1 drugs.
What the court ruling does—and does not—settle
The Fifth Circuit concluded that FDA had engaged in reasoned decision-making and reasonably explained its assessment of the evidence on tirzepatide supply and demand. That ruling upheld the judgment in the shortage litigation; it was not a finding that every patient can readily get an approved drug, nor a ruling that all compounding is prohibited.
Rank #2
- FOOD JOURNAL FOR HEALTHY - A food journal to tracks daily dietary and nutritional intake for women/men. It will help you stay healthy, get motivated, get rid of bad habits, and achieve your weight loss goals. Focus on your health and eat healthy, this food tracker is all about what you want to improve.
- ACHIEVE GOALS - This fitness and nutrition journal helps you set big goals, break them down into monthly milestones, and work relentlessly toward them. At the end of each month, you will complete a monthly review to reflect your progress.
- UNDATED 6 MONTH MEAL PLANNER - This is a food diary that tracks meals and exercise last for 6 month. Keep daily records of calories, sleep time, water, weight, body fat, and activity. The monthly record can help you pay attention to your health and notice how changing your diet and lifestyle affects how you feel.
- ADDITIONAL - Lovely patterns created by hardcover, high quality of size 5.8" x 8.3", There are 3 sheets colorful stickers to help you plan and stay motivated to continue using this daily journal. What's more, the food journal with 3 ribbon bookmark, elastic band, pen holder and inner pocket for easy use.
- GUARANTEE - If you have any problems with this food journal, please contact us and we will help you solve promptly!
National supply and an individual patient’s access are not identical. The opinion discussed barriers including price, insurance, pharmacy operations, and supply-chain dynamics. A shortage determination can therefore matter to the legal conditions for compounding without resolving whether a specific patient can afford or obtain an approved prescription.
What the FDA proposal means for 503B facilities
The 503B bulks list concerns whether outsourcing facilities may compound certain drugs from bulk drug substances under the relevant statutory framework. FDA’s April 30 action proposed removing semaglutide, tirzepatide, and liraglutide from that list. The agency said, “When FDA-approved drugs are available, outsourcing facilities cannot lawfully compound using bulk drug substances unless there is a clear clinical need,” according to FDA Commissioner Marty Makary, M.D., M.P.H., in the announcement.
A proposal is not a final determination. FDA invited comments through June 29, 2026, and said it would consider them before deciding. The April announcement alone does not establish a final outcome. Nor does the proposed 503B action answer every question about 503A compounding, which operates under different conditions.
Safety and quality issues patients should understand
FDA has described risks associated with unapproved compounded GLP-1 products, including dosing mistakes when measuring or calculating doses, use beyond labeled doses or titration schedules, improper refrigeration during shipping, and risks from using multidose sterile vials more than 28 days after first use. The agency has also warned about semaglutide salt forms and fraudulent products. These are reasons to discuss a specific product and prescription with a licensed clinician and pharmacist rather than assume a compounded product is interchangeable with an approved one.
Rank #4
- 150-day/5-month food and fitness journal with measuring tape: this fitness journal allows you to record up to 150 days of fitness and diet data, ensuring you stay on track with your health goals. The measuring tape helps you to track your body dimensions and detailed tracking system helps you monitor progress and make necessary adjustments to your routine
- Structured goal setting and achievement: the 2 goal pages of fitness planner has 10 sections for setting clear objectives, start and end dates, detailed plans, and results. The workout journal also features a reward section to motivate you to achieve your fitness milestones
- Body dimension contrasts by table, photos and chart: the body dimension contrasts can be shown by figures, photos, and progress curves. This visual representation allows you to see tangible changes in your physique over time, providing motivation and a clear sense of achievement
- Integrated calendar and daily tracking: the 2-page undated calendar of weight loss journal provides a monthly overview with daily completion marks and progress curves. The daily tracking pages allow you to log specific exercises, calories burned, and meal calorie intake. This integrated system helps you maintain a consistent routine and stay accountable to your fitness and nutrition goals
- User-friendly design, durable material: the 9.5'' * 7'' fitness journal for women is easy to carry and use, with a waterproof and sweat-proof PP material cover and ink-resistant 100gsm thick paper inside. The elastic band keeps the workout planner closed to keep your data private and organized. Double sided pockets are designed for cards, guidebooks, etc.
FDA reported 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide as of May 31, 2026. Those are reports, not confirmed counts of reactions caused by the drugs: FDA says reports do not always establish causation. The agency also says reports are likely undercounted because certain state-licensed pharmacies are not required to submit them.
Refrigeration and delivery
FDA says injectable GLP-1 drugs require refrigeration as directed in their product package inserts. It advises patients not to use an injectable GLP-1 drug that arrives warm or without sufficient refrigeration because product quality may be affected. A home refrigerator thermometer can show the refrigerator’s temperature; it cannot verify a shipment’s temperature history or make a product safe if its storage conditions are uncertain.
Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesBest Value
- SMASH YOUR PB'S - Achieve the performance and physique you've always wanted with Nextnoid daily workout journal! Effectively track both daily and weekly workout goals upto 8 months as meticulously as you desire, plan next week's workouts, and celebrate your success with ease. Stay focused!
- GET FITTER, FASTER - Take control of your health and fitness journey and accelerate your results with our fitness planner for women and men! This exercise diary provides you with a proven system to build muscle, improve strength or just be healthier. What gets measured, improves!
- SIMPLE AND CLEAR - Setting yourself up for success has never been easier! Our personal workout book takes the thought and effort out of staying disciplined and accountable with a clear incremental progress system, bigger fonts for easy reading and enough space to jot down everything.
- CAREFULLY CRAFTED - Made with functionality and also long-lasting durability in mind with size 5.7x8.3 in, this fit log journal is tough enough to withstand the rigors of the gym floor, running trail and even the kitchen! Premium thick 120gsm pages and a sweat and tear-proof outer match your grit!
- PERFECT GIFT - Show the fitness enthusiast in your life just how much you care with this workout tracker notebook! Also ideal for the beginner who dreams of being in shape, this fitness training journal could be the motivation they need to kickstart their health and wellness journey!
Practical questions to ask before choosing a compounded product
- What exactly is being prescribed? Confirm the active ingredient, formulation, dose, and whether the product is FDA-approved or compounded.
- Why is compounding being used in this case? Ask the prescriber to explain the patient-specific reason and which compounding pathway applies.
- How should it be stored and measured? Get the product-specific refrigeration instructions and clear directions for measuring each dose; do not transfer dosing instructions from a different pen, vial, or formulation.
- What happens if supply or affordability is the obstacle? Ask the clinician and pharmacist about approved-product availability, insurance coverage, and other appropriate treatment options. The court’s recognition of access barriers does not establish that a compounded product is equivalent or suitable for an individual patient.
This is U.S. federal regulatory context, not individualized medical advice. For a treatment decision, consult a qualified clinician who can assess the specific product, prescription, and patient.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
